Related Articles Nanotechnology in pulmonary medicine Curr Opin Pharmacol 2020 Dec 17 56 85 92 Authors Doroudian M O Neill A Mac Loughlin R Prina Mello A Volkov Y Donnelly SC Abstract Nanotechnology in medicine nanomedicine is extensively employed to diagnose treat and prevent pulmonary diseases Over the last few years this brave new world has made remarkable progress offering opportunities to address historical clinical challenges in pulmonary diseases including multidrug resistance adverse side effects of conventional therapeutic agents novel imaging and earlier disease detection Nanomedicine is also being applied to tackle the new emerging infectious diseases including severe acute respiratory syndrome coronavirus SARS CoV Middle East Respiratory Syndrome Coronavirus MERS CoV influenza A virus subtype H1N1 A H1N1 and more recently severe acute respiratory syndrome coronavirus 2 SARS CoV 2 In this review we provide both a historical overview of the application of nanomedicine to respiratory diseases and more recent cutting edge approaches such as nanoparticle mediated combination therapies novel double targeted nondrug delivery system for targeting stimuli responsive nanoparticles and theranostic imaging in the diagnosis and treatment of pulmonary diseases PMID 33341460 PubMed as supplied by publisher